期刊文献+

经皮冠状动脉介入治疗对冠心病合并心力衰竭患者疗效评价 被引量:10

Effect of percutaneous coronary interventions on heart function in patients with coronary heart disease and heart failure disease
下载PDF
导出
摘要 目的观察经皮冠状动脉介入治疗对冠心病患者左心室收缩和舒张功能的疗效。方法选择72例冠心病合并心力衰竭的患者,行经皮冠状动脉介入治疗,术前、术后1周和术后6个月分别行心脏超声检查左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、左室短轴缩短率(FS)、左室射血分数(LVEF)、舒张早期血流峰值速度(E)、舒张晚期血流峰值速度(A)以及E峰和A峰比值(E/A),比较术前和术后患者心功能变化情况。结果通过行介入治疗后,支架植入术后冠心病合并心力衰竭患者心功能较前有了明显的好转,术后6个月LVEF、FS、LVESD、LVEDD、E、A和E/A与术前相比均有明显改善(P<0.05和0.01),术后一周LVEF和FS与术前相比有改善(P<0.05)。术后6个月与术后一周相比LVEF、FS、LVESD和LVEDD有明显改善(P<0.05)。结论经皮冠状动脉介入治疗能够明显改善冠心病合并心力衰竭患者的心功能。 Objective To investigate the effect on left ventricular systolic and diastolic function in patients with coronary heart disease(CHD) after percutaneous coronary interventions(PCI).Methods 72 CHD patients with heart failure disease who underwent PCI were selected.Left ventricular end systolic diameter(LVESD),Left ventricular end diastolic diameter(LVEDD),Fraction shortening(FS),Left ventricular ejection(LVEF),E,A and E/A were measured with Doppler echocardiography before operation,one weeks and 6 months after operation.Results SAfter percutaneous coronary interventions,the systolic and diastolic function in CHD patients with heart failure were significantly improved.LVEF、FS、LVESD、LVEDD、E、A and E/A were significantly improved(P〈0.05,0.01) six months after operation compared with before operation.LVEF and FS were improved(P〈0.05) one week after operation compared with before operation.LVEF、FS、LVESD and LVEDD were improved(P〈0.05) six months after operation compared with one week after operation.Conclusion The systolic and diastolic function in CHD patients with heart failure were inproved after percutaneous coronary interventions.
出处 《中国临床保健杂志》 CAS 2009年第6期575-577,共3页 Chinese Journal of Clinical Healthcare
关键词 冠心病 心力衰竭 血管假体植入 超声心动描记术 多普勒 彩色 Coronary disease Heart failure Blood vessel prosthesis implantation Echocardiography doppler color
  • 相关文献

参考文献3

二级参考文献16

  • 1高焱章,李玉梅.卡维地洛对慢性充血性心力衰竭患者心功能及心率变异性的影响[J].新乡医学院学报,2005,22(1):31-32. 被引量:2
  • 2刘江峰,孙同文,唐璐,茹祥伟.监测脑钠肽水平评价美托洛尔治疗慢性心力衰竭的疗效[J].新乡医学院学报,2005,22(5):483-484. 被引量:5
  • 3关建华,高焱章.卡维地洛对慢性充血性心力衰竭者心功能及血浆内皮素-1和降钙素基因相关肽的影响[J].新乡医学院学报,2006,23(1):59-61. 被引量:7
  • 4Bax JJ, Van der Wall EE. Assessment of myocardial viability:guide to prognosis and clinical management. Eur Heart J, 2000,21 (12) :961-963.
  • 5Bax JJ, Wijns W, Cornel JH, et al. Accuracy of currently available techniques for prediction of functional recorvey after revascularizaton in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997.30 (6) : 1451-1460.
  • 6Afridi I, Grayburn PA, Panza JA, et al. Mycardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol , 1998,32 (4) :921-926.
  • 7Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left vetricular dysfunction: a meta-analysis. J Am Coll Cardiol , 2002,39 ( 7 ) : 1151-1158.
  • 8Bounous EP, Mark DB, Pollock BG, et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation,1988, 78(3 Pt2) :I 151- I 157.
  • 9Di Sciascio G, Patti G, D'Ambrosio A, et al. Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population. Cather Cardiovasc Interv, 2003,59 (4) :429 -433.
  • 10徐济民.缺血性心脏病诊断的命名及标准-国际心脏病学会和协会/世界卫生组织临床命名标准化专题组的联合报告.国际心血管病杂志,1979,(06):31-33.

共引文献14

同被引文献85

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部